Tuberculosis
Infectious Disease · ~7% of blueprint- Pathophysiology
- Mycobacterium tuberculosis (acid-fast) inhaled → granulomatous lung infection; can reactivate.
- Signs & Symptoms
- Chronic cough, hemoptysis, night sweats, weight loss, fever; classically upper-lobe disease.
- Gold Standard Diagnosis
- Sputum acid-fast smear & culture (gold standard) + NAAT; CXR; IGRA/PPD for latent TB.
- First-line Treatment
- RIPE — Rifampin, Isoniazid, Pyrazinamide, Ethambutol (2 mo), then RI (4 mo). Latent: short-course rifamycin (3HP/4R/3HR) preferred.
High-Yield Pearl
Isoniazid causes peripheral neuropathy — give pyridoxine (B6) to those at risk.
Practice this
Learn it in your courses
Immunology & Genetics
Sources
Reviewed September 2026- Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline — ATS / CDC / ERS / IDSA, 2025
- Treatment for Drug-Susceptible Tuberculosis Disease; Treatment for Latent TB Infection (CDC TB clinical treatment pages) — U.S. Centers for Disease Control and Prevention, 2024
- Official ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis — ATS / CDC / IDSA, 2016
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
More Infectious Disease conditions
Got your lecture on Tuberculosis? Turn it into flashcards and board-style questions, free. Drop it on the home page
All Infectious Disease